Description:
Lantus Solostar is a pre-filled pen containing insulin glargine, a long-acting basal insulin used to manage blood sugar levels in individuals with diabetes mellitus (Type 1 and Type 2).

Prescription:

• Required.

Dosage:

• Dosage is individualized based on the patient’s blood sugar levels and doctor’s prescription.
• Typically administered once daily, at the same time each day.
• Administered subcutaneously (under the skin).

Therapeutic Category:

• Antidiabetic – Long-acting Insulin.

Active Ingredients/Composition:

• Insulin Glargine (100 IU/mL).

Variant:

• Pre-filled pen device containing 3 mL of solution per pen.

Consume Type:

• Injectable.

Directions/Usage:

• Check the pen for clarity of the insulin; it should be clear and colorless.
• Attach a new needle to the pen.
• Prime the pen to remove air bubbles.
• Set the prescribed dose on the pen.
• Inject subcutaneously into the abdomen, thigh, or upper arm.
• Dispose of the needle safely after each use.

Common Side Effects:

• Hypoglycemia (low blood sugar).
• Injection site reactions (e.g., redness, swelling, or itching).
• Weight gain.
• Allergic reactions (rare).

Package Type:

• Box containing multiple pre-filled pens (e.g., 5 pens).

Storage Advice:

• Store unopened pens in the refrigerator (2°C – 8°C).
• Once in use, store at room temperature (below 30°C) for up to 28 days.
• Protect from heat and direct sunlight.
• Do not freeze.

Safety Advice:

• Regularly monitor blood sugar levels to avoid hypoglycemia or hyperglycemia.
• Never share pens or needles.
• Rotate injection sites to prevent lipodystrophy (changes in fat tissue under the skin).
• Inform your doctor if pregnant, breastfeeding, or taking other medications.

Product Substitutes:

• Basaglar KwikPen (Insulin Glargine).
• Toujeo Solostar (Insulin Glargine U-300).

Manufacturer/Marketer:

• Sanofi.

Country of Origin:

• France